Function of metal transporter ZIP14 as regulated by proinflammatory stimuli

促炎刺激调节金属转运蛋白 ZIP14 的功能

基本信息

  • 批准号:
    8219465
  • 负责人:
  • 金额:
    $ 28.68万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2011
  • 资助国家:
    美国
  • 起止时间:
    2011-09-23 至 2016-08-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Zinc is an essential micronutrient that is required to maintain health. The underlying mechanisms are unknown, but evidence is emerging that zinc has roles in control of signaling pathways, e.g. protein kinases, protein phosphatases and transcription factor phosphorylation. The role is similar to that of calcium where the intracellular ion concentration controls functions. Cells use 24 different zinc transporter proteins derived from two gene families to direct zinc ions to intracellular sites. Some zinc transporter genes respond to the dietary zinc supply and participate in homeostasis, whereas a few others are regulated by cytokines and hormones. We have identified two zinc transporter genes Zip8 and Zip14, which respond to proinflammatory cytokines. ZIP8 mediated transport of Zn2+ from lysosomes of activated T cells maintains CREB in its phosphorylated forum enabling enhanced IFNy transcription. We have demonstrated that Zip14 is induced in hepatocytes upon stimulation by IL6, IL12 and nitric oxide. ZIP14 stimulates Zn2+ transport and has functional outcomes such as interaction with the metal responsive transcription factor, MTF1. The focus of this proposal is to explore the physiologic role of ZIP14 using Zip14 knockout mice. Our hypothesis for this project is that Zip14 is up-regulated by pro-inflammatory conditions and transports zinc for functions in liver, the gastrointestinal tract, and muscle. We will test our hypothesis through three interconnected specific aims: 1. Characterize the phenotype of the Zip14-/- mouse including the effects of Zip14 deletion on metal transport in vivo and in primary cells. 2. Evaluate the involvement of ZIP14 in murine liver regeneration and during inflammatory responses. 3. Physiologic consequences of Zip14 Deletion and Expression in signaling pathways in liver, gastrointestinal tract and muscle during inflammation. The rationale for these experiments is that the ZIP14 (SLC39A14) transporter is responsive to proinflammatory stimuli and hence is dysregulated in many pathophysiologic conditions producing altered zinc signaling. These may benefit from zinc supplementation or drugs designed to influence ZIP14 activity. PUBLIC HEALTH RELEVANCE: There is strong evidence for the biochemical roles of zinc, however, we do not have a clear understanding of how these functions maintain health. Research from this project is relevant to NIH's mission as it addresses how humans acquire and utilize zinc in an integrative manner, via regulated expression of zinc transporters, to effectively maximize functions of this micronutrient in the promotion of health. This project will examine the expression and function of a zinc transporter (ZIP14) that is dramatically up-regulated by pro-inflammatory conditions using a gene knockout model. We will examine how ZIP14 expression in the gastrointestinal tract, liver and muscle influences metal ion transport and specific cell signaling pathways. Since ZIP14 is increased during inflammation zinc supplementation or drugs targeting ZIP14 activity may influence related to inflammation.
说明(申请人提供):锌是维持健康所必需的微量营养素。其潜在的机制尚不清楚,但有证据表明,锌在信号通路中具有控制作用,如蛋白激酶、蛋白磷酸酶和转录因子磷酸化。这种作用类似于细胞内离子浓度控制功能的钙。细胞使用来自两个基因家族的24种不同的锌转运蛋白将锌离子引导到细胞内位置。一些锌转运蛋白基因对膳食锌供应做出反应并参与体内平衡,而另一些基因则受细胞因子和激素的调节。我们已经鉴定了两个锌转运蛋白基因ZIP8和Zip14,它们对促炎细胞因子做出反应。ZIP8介导的锌离子从激活的T细胞溶酶体的转运使CREB保持在其磷酸化的论坛上,从而增强了IFNy的转录。我们已经证明,在IL6、IL12和一氧化氮刺激下,Zip14在肝细胞中被诱导。ZIP14可刺激锌离子的转运,并具有与金属反应转录因子MTF1相互作用等功能。这项建议的重点是利用Zip14基因敲除小鼠来探索ZIP14的生理作用。我们对这个项目的假设是,Zip14在促炎条件下上调,并运输锌在肝脏、胃肠道和肌肉中的功能。我们将通过三个相互关联的特定目标来验证我们的假设:1.表征Zip14-/-小鼠的表型,包括Zip14缺失对体内和原代细胞中金属运输的影响。2.探讨ZIP14在小鼠肝再生和炎症反应中的作用。3.炎症过程中肝脏、胃肠道和肌肉信号通路中Zip14基因缺失和表达的生理学后果。这些实验的基本原理是ZIP14(SLC39A14)转运蛋白对促炎刺激有反应,因此在许多病理生理条件下调节失调,产生改变的锌信号。这些人可能受益于补锌或旨在影响ZIP14活性的药物。 与公共健康相关:有强有力的证据表明锌的生化作用,然而,我们还不清楚这些功能是如何维持健康的。该项目的研究与NIH的使命相关,因为它解决了人类如何通过锌转运蛋白的调控表达以综合方式获取和利用锌,以有效地最大化这种微量营养素在促进健康方面的功能。这个项目将使用基因敲除模型来研究锌转运蛋白(ZIP14)的表达和功能,该转运蛋白在促炎条件下显著上调。我们将研究ZIP14在胃肠道、肝脏和肌肉中的表达如何影响金属离子的运输和特定的细胞信号通路。由于ZIP14在炎症过程中升高,补锌或针对ZIP14活性的药物可能会影响与炎症相关的因素。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ROBERT J COUSINS其他文献

ROBERT J COUSINS的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ROBERT J COUSINS', 18)}}的其他基金

15th International Symposium on Trace Elements in Man and Animals (TEMA15)
第十五届国际人和动物微量元素研讨会(TEMA15)
  • 批准号:
    8720288
  • 财政年份:
    2014
  • 资助金额:
    $ 28.68万
  • 项目类别:
Function of metal transporter ZIP14 as regulated by proinflammatory stimuli
促炎刺激调节金属转运蛋白 ZIP14 的功能
  • 批准号:
    8335469
  • 财政年份:
    2011
  • 资助金额:
    $ 28.68万
  • 项目类别:
Function of metal transporter ZIP14 as regulated by proinflammatory stimuli
促炎刺激调节金属转运蛋白 ZIP14 的功能
  • 批准号:
    8535747
  • 财政年份:
    2011
  • 资助金额:
    $ 28.68万
  • 项目类别:
Function of metal transporter ZIP14 as regulated by proinflammatory stimuli
促炎刺激调节金属转运蛋白 ZIP14 的功能
  • 批准号:
    8721947
  • 财政年份:
    2011
  • 资助金额:
    $ 28.68万
  • 项目类别:
Function of Metal Transporter ZIP14 as Regulated by Proinflammatory Stimuli
促炎刺激调节金属转运蛋白 ZIP14 的功能
  • 批准号:
    9382363
  • 财政年份:
    2011
  • 资助金额:
    $ 28.68万
  • 项目类别:
Function of Metal Transporter ZIP14 as Regulated by Proinflammatory Stimuli
促炎刺激调节金属转运蛋白 ZIP14 的功能
  • 批准号:
    10474233
  • 财政年份:
    2011
  • 资助金额:
    $ 28.68万
  • 项目类别:
Zinc and the Synthesis of Binding Proteins
锌与结合蛋白的合成
  • 批准号:
    8099333
  • 财政年份:
    2010
  • 资助金额:
    $ 28.68万
  • 项目类别:
REGULATION OF UROGUANYLIN BY DIETARY ZINC STATUS
膳食锌状况对尿鸟苷素的调节
  • 批准号:
    2905983
  • 财政年份:
    1998
  • 资助金额:
    $ 28.68万
  • 项目类别:
REGULATION OF UROGUANYLIN BY DIETARY ZINC STATUS
膳食锌状况对尿鸟苷素的调节
  • 批准号:
    2627022
  • 财政年份:
    1998
  • 资助金额:
    $ 28.68万
  • 项目类别:
RESEARCH TRAINING IN NUTRITION
营养研究培训
  • 批准号:
    2770316
  • 财政年份:
    1994
  • 资助金额:
    $ 28.68万
  • 项目类别:

相似海外基金

Development of small molecule inhibitors as anti-inflammatory agents and antidotes for arsenicals
开发作为抗炎剂和砷解毒剂的小分子抑制剂
  • 批准号:
    10727507
  • 财政年份:
    2023
  • 资助金额:
    $ 28.68万
  • 项目类别:
Discovery of New Anti-Inflammatory Agents to Treat COPD
发现治疗慢性阻塞性肺病的新型抗炎药
  • 批准号:
    9194162
  • 财政年份:
    2016
  • 资助金额:
    $ 28.68万
  • 项目类别:
Synthesis of anti-inflammatory agents and their structure-activity relationships studies
抗炎药的合成及其构效关系研究
  • 批准号:
    496858-2016
  • 财政年份:
    2016
  • 资助金额:
    $ 28.68万
  • 项目类别:
    University Undergraduate Student Research Awards
NAAA Inhibitors as Anti-inflammatory Agents, Phase II
NAAA 抑制剂作为抗炎剂,II 期
  • 批准号:
    9201955
  • 财政年份:
    2015
  • 资助金额:
    $ 28.68万
  • 项目类别:
Novel flavonoids as anti-inflammatory agents in alcoholism
新型黄酮类化合物作为酒精中毒的抗炎剂
  • 批准号:
    8251289
  • 财政年份:
    2014
  • 资助金额:
    $ 28.68万
  • 项目类别:
TLR-7 Agonists as Targeted Anti-inflammatory Agents in Arthritis
TLR-7 激动剂作为关节炎的靶向抗炎药
  • 批准号:
    8302750
  • 财政年份:
    2012
  • 资助金额:
    $ 28.68万
  • 项目类别:
Design and in vivo delivery of novel anti-inflammatory agents
新型抗炎剂的设计和体内递送
  • 批准号:
    267940
  • 财政年份:
    2012
  • 资助金额:
    $ 28.68万
  • 项目类别:
    Operating Grants
Development of inlammasome inhibitors to be used as anti-inflammatory agents
开发用作抗炎剂的inlammasome抑制剂
  • 批准号:
    8403458
  • 财政年份:
    2012
  • 资助金额:
    $ 28.68万
  • 项目类别:
Development of inlammasome inhibitors to be used as anti-inflammatory agents
开发用作抗炎剂的inlammasome抑制剂
  • 批准号:
    8549297
  • 财政年份:
    2012
  • 资助金额:
    $ 28.68万
  • 项目类别:
TLR-7 Agonists as Targeted Anti-inflammatory Agents in Arthritis
TLR-7 激动剂作为关节炎的靶向抗炎药
  • 批准号:
    8472443
  • 财政年份:
    2012
  • 资助金额:
    $ 28.68万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了